GB0104840D0 - Use of organic compounds - Google Patents

Use of organic compounds

Info

Publication number
GB0104840D0
GB0104840D0 GBGB0104840.4A GB0104840A GB0104840D0 GB 0104840 D0 GB0104840 D0 GB 0104840D0 GB 0104840 A GB0104840 A GB 0104840A GB 0104840 D0 GB0104840 D0 GB 0104840D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0104840.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0104840.4A priority Critical patent/GB0104840D0/en
Publication of GB0104840D0 publication Critical patent/GB0104840D0/en
Priority to TW094130192A priority patent/TWI343258B/en
Priority to TW091103305A priority patent/TWI303170B/en
Priority to NZ527764A priority patent/NZ527764A/en
Priority to AT02744903T priority patent/ATE434438T1/en
Priority to SK1071-2003A priority patent/SK287489B6/en
Priority to KR1020037011205A priority patent/KR100848197B1/en
Priority to HU0303333A priority patent/HUP0303333A3/en
Priority to IL15746602A priority patent/IL157466A0/en
Priority to CZ20032277A priority patent/CZ20032277A3/en
Priority to ES02744903T priority patent/ES2326264T3/en
Priority to CA002439268A priority patent/CA2439268C/en
Priority to BR0207649-7A priority patent/BR0207649A/en
Priority to EP02744903A priority patent/EP1385522B1/en
Priority to PCT/EP2002/002049 priority patent/WO2002067941A2/en
Priority to DK02744903T priority patent/DK1385522T3/en
Priority to PT02744903T priority patent/PT1385522E/en
Priority to DE60232719T priority patent/DE60232719D1/en
Priority to AU2002308218A priority patent/AU2002308218B2/en
Priority to US10/469,367 priority patent/US7723339B2/en
Priority to JP2002567308A priority patent/JP4499359B2/en
Priority to CN028056086A priority patent/CN1511036B/en
Priority to RU2003127392/15A priority patent/RU2313345C2/en
Priority to MXPA03007729A priority patent/MXPA03007729A/en
Priority to PL363288A priority patent/PL207197B1/en
Priority to ZA200306404A priority patent/ZA200306404B/en
Priority to IL157466A priority patent/IL157466A/en
Priority to NO20033769A priority patent/NO325416B1/en
Priority to HK04105220.7A priority patent/HK1062266A1/en
Priority to CY20091100900T priority patent/CY1109347T1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0104840.4A 2001-02-27 2001-02-27 Use of organic compounds Ceased GB0104840D0 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
GBGB0104840.4A GB0104840D0 (en) 2001-02-27 2001-02-27 Use of organic compounds
TW094130192A TWI343258B (en) 2001-02-27 2002-02-25 Combination comprising an active ingredient which decreases the activity of the epidermal growth factor (egf) and an epothilone derivative
TW091103305A TWI303170B (en) 2001-02-27 2002-02-25 Combination comprising a platelet-derived growth factor(pdgf) receptor tyrosine kinase inhibitor and an epothilone derivative
PL363288A PL207197B1 (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative
PCT/EP2002/002049 WO2002067941A2 (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative
PT02744903T PT1385522E (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative
SK1071-2003A SK287489B6 (en) 2001-02-27 2002-02-26 Combination of PDGF receptor tyrosine kinase inhibitor and epothilone derivative, pharmaceutical composition comprising the combination and use thereof
KR1020037011205A KR100848197B1 (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative
HU0303333A HUP0303333A3 (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative and pharmaceutical composition containing it
IL15746602A IL157466A0 (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative
CZ20032277A CZ20032277A3 (en) 2001-02-27 2002-02-26 Combination of signal transmission inhibitor and epothilone derivative for treating proliferative diseases
ES02744903T ES2326264T3 (en) 2001-02-27 2002-02-26 COMBINATION THAT INCLUDES A SIGNAL TRANSDUCTION INHIBITOR AND AN EPOTILONE DERIVATIVE.
CA002439268A CA2439268C (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative
BR0207649-7A BR0207649A (en) 2001-02-27 2002-02-26 A combination comprising a signal transduction inhibitor and an epothilone derivative
EP02744903A EP1385522B1 (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative
NZ527764A NZ527764A (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative
DK02744903T DK1385522T3 (en) 2001-02-27 2002-02-26 Combination containing a signal transduction inhibitor and an epothilone derivative
AT02744903T ATE434438T1 (en) 2001-02-27 2002-02-26 COMBINATION CONTAINING A SIGNAL TRANSDUCTION INHIBITOR AND AN EPOTHILONE DERIVATIVE
DE60232719T DE60232719D1 (en) 2001-02-27 2002-02-26 COMBINATION CONTAINED AN INHIBITOR OF SIGNAL TRANSDUCTION AND AN EPOTHILONE DERIVATIVE
AU2002308218A AU2002308218B2 (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative
US10/469,367 US7723339B2 (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative
JP2002567308A JP4499359B2 (en) 2001-02-27 2002-02-26 Combination comprising a signal conversion inhibitor and an epothilone derivative
CN028056086A CN1511036B (en) 2001-02-27 2002-02-26 Combination comprising signal transduction inhibitor and epothilone derivative
RU2003127392/15A RU2313345C2 (en) 2001-02-27 2002-02-26 Combinations containing transduction signal inhibitor and epotilone derivative
MXPA03007729A MXPA03007729A (en) 2001-02-27 2002-02-26 Combination comprising a signal transduction inhibitor and an epothilone derivative.
IL157466A IL157466A (en) 2001-02-27 2003-08-18 Combinations comprising a signal transduction inhibitor and an epothilone derivative, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for delay of progression or treatment of proliferative diseases
ZA200306404A ZA200306404B (en) 2001-02-27 2003-08-18 Combination comprising a signal transduction inhibitor and an epothilone derivative.
NO20033769A NO325416B1 (en) 2001-02-27 2003-08-25 A combination comprising a signal transduction inhibitor and an epothilone derivative, a pharmaceutical composition containing said combination, and its use in the treatment of a proliferative disease.
HK04105220.7A HK1062266A1 (en) 2001-02-27 2004-07-15 Combination comprising a signal transduction inhibitor and an epothilone derivative
CY20091100900T CY1109347T1 (en) 2001-02-27 2009-08-28 Combination consisting of a signal transducer inhibitor and a subunit derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0104840.4A GB0104840D0 (en) 2001-02-27 2001-02-27 Use of organic compounds

Publications (1)

Publication Number Publication Date
GB0104840D0 true GB0104840D0 (en) 2001-04-18

Family

ID=9909622

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0104840.4A Ceased GB0104840D0 (en) 2001-02-27 2001-02-27 Use of organic compounds

Country Status (5)

Country Link
CZ (1) CZ20032277A3 (en)
GB (1) GB0104840D0 (en)
HU (1) HUP0303333A3 (en)
TW (2) TWI303170B (en)
ZA (1) ZA200306404B (en)

Also Published As

Publication number Publication date
TW200602060A (en) 2006-01-16
TWI343258B (en) 2011-06-11
TWI303170B (en) 2008-11-21
CZ20032277A3 (en) 2004-01-14
HUP0303333A2 (en) 2004-01-28
HUP0303333A3 (en) 2004-05-28
ZA200306404B (en) 2004-06-07

Similar Documents

Publication Publication Date Title
PL365696A1 (en) Combination of organic compounds
AU7393801A (en) Combination of organic compounds
GB0103389D0 (en) Organic compounds
GB0103303D0 (en) Organic compounds
GB0108087D0 (en) Organic compounds
GB0107368D0 (en) Organic compounds
GB0103258D0 (en) Organic compounds
GB0101598D0 (en) Organic compounds
GB0107365D0 (en) Organic compounds
GB0102841D0 (en) Organic compounds
GB0124732D0 (en) Use of organic compounds
GB0104840D0 (en) Use of organic compounds
TW512752U (en) Purifier of organic compounds
GB0028467D0 (en) Use of organic compounds
GB0126884D0 (en) Dehalogenation of organic compounds
GB0104072D0 (en) Organic compounds
GB0104438D0 (en) Organic compounds
GB0102839D0 (en) Organic compounds
GB0102380D0 (en) Organic compounds
GB0103047D0 (en) Organic Compounds
GB0102090D0 (en) Organic compounds
GB0102089D0 (en) Organic Compounds
GB0104070D0 (en) Organic compounds
GB0102379D0 (en) Organic compounds
GB0102088D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)